Although California's governor hoped to have the cheaper insulin available by last year, it may take at least another two years.

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which ...

This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...

The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...

has announced that the US Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old ...

Newsom’s insulin fail. A drive by California Gov. Gavin Newsom to make low-cost insulin by spending $100 million in state ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

This past year featured key developments in the prescription drug policy area, including the implementation of significant ...